The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site

Isabelle Mahé, Jean Chidiac, Laurent Bertoletti, +135

The American Journal of Medicine

Clinical CourseThrombosisPulmonary EmbolismVenous DiseaseCancer Site +11

Whole blood clots are more resistant to lysis than plasma clots - greater efficacy of rivaroxaban

R. Varin, Shahsultan Mirshahi, Pezhman Mirshahi, +7

Thrombosis Research

ThrombosisGreater EfficacyWhole Blood ClotsHematologyHemostasis +6

Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism

Isabelle Mahé, Marc Carrier, D. Mayeur, +32

New England Journal of Medicine

Abstract S1-6: TAMRAD: A GINECO Randomized Phase II Trial of Everolimus in Combination with Tamoxifen Versus Tamoxifen Alone in Patients (pts) with Hormone-Receptor Positive, HER2 Negative Metastatic Breast Cancer (MBC) with Prior Exposure to Aromatase Inhibitors (AI).

T Bachelot, C. Bourgier, Claire Cropet, +11

Cancer Research

Breast OncologyPharmacotherapyEndocrine OncologyOncologyClinical Trials +14

Endothelial protein C receptor expressed by ovarian cancer cells as a possible biomarker of cancer onset

E. Ducros, Shahsoltan Mirshahi, Dalel Azzazene, +10

International Journal of Oncology

ImmunologyGynecologyPathologyCancer BiologyTumor Biology +16

Ovarian cancer: Stat3, RhoA and IGF-IR as therapeutic targets

Caroline Gest, Pezhman Mirshahi, Hong Li, +12

Cancer Letters

GynecologyMedicineOvarian HormoneTumor BiologyEndocrine-related Cancer +1

Adherence to treatment guidelines for cancer-associated thrombosis: a French hospital-based cohort study

Isabelle Mahé, Hortense Puget, Jean‐Claude Buzzi, +5

Supportive Care in Cancer

ThrombosisTreatment GuidelinesVenous ThrombosisOncologyHealth Policy +8

Patients experience of living with cancer associated thrombosis in France (Le PELICAN)

Isabelle Mahé, Jean Chidiac, Mickaël Pinson, +4

Thrombosis Research

ThrombosisPulmonary EmbolismPatients ExperienceLe PelicanVenous Thrombosis +7

A clinical experience of single agent bevacizumab in relapsing ovarian cancer

George Emile, L. Chauvenet, Jean‐Marie Tigaud, +3

Gynecologic Oncology

Single Agent BevacizumabMedicineCancer ManagementGynecologyCancer Treatment +5

Effect of Rivaroxaban, An Oral Direct Factor Xa Inhibitor, On Whole Blood Clot Permeation and Thrombolysis: Critical Role of Red Blood Cells.

R. Varin, Shahsultan Mirshahi, Pehzman Mirshahi, +6

Blood